Opto Biosystems develops healthcare tech linking cancer neuroscience with bioelectronics for new treatments.
Opto Biosystems has raised $2.3M in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2023.
Opto Biosystems's investors include Blackbird Ventures, Possible Ventures, Amar Shah.
Opto Biosystems is headquartered in Cambridge, United Kingdom.
Opto Biosystems develops healthcare tech linking cancer neuroscience with bioelectronics for new treatments.
Opto Biosystems is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Opto Biosystems — Funding & Investors." VCBacked, March 13, 2023, https://www.vcbacked.co/company/opto-biosystems. Accessed September 15, 2026.
VCBacked. (2023). Opto Biosystems — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/opto-biosystems
{{cite web |title=Opto Biosystems — Funding & Investors |url=https://www.vcbacked.co/company/opto-biosystems |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated